ACTOS Bladder Cancer Lawsuit. This since settled litigation involved the possible link between the type 2 diabetes drug Actos and bladder cancer. These cases settled for an average of nearly $300,000 per claim. The drug is still on the market but, as we talk about below, with a black box warning that apprises of the risk.

Jul 30, 2020 · People filing Actos lawsuits claim that the anti-diabetic medication played a role in the development of bladder cancer. The lawsuits accuse the manufacturer, Takeda Pharmaceutical Company, of hiding the relationship between the drug and the cancer from patients and healthcare providers.

May 1, 2020 · By filing an Actos lawsuit, you may be able to recover compensation for damages, which cover economic and non-economic losses related to your bladder cancer diagnosis. This may include compensation for medical expenses, lost wages, pain and suffering, and in cases of death, funeral expenses.

Apr 8, 2014 · Following more than 12 weeks of trial, it took a Louisiana jury only a few hours to return a verdict in the first federal case involving the development of bladder cancer from side effects of...

Billions of dollars in settlements and jury verdicts have been awarded to plaintiffs in Actos® pharmaceutical lawsuits, with many cases still pending. In 2015, manufacturer Takeda Pharmaceuticals agreed to pay a $2.37 billion in Actos® settlements to resolve over 9,000 state and federal cases.

Takeda Pharmaceuticals will pay approximately $2.4 billion to settle Actos lawsuits. Actos and some associated drugs (ActoPlus Met XR, Duetact, or ActoPlus Met) are Type II diabetes medications manufactured by Japan-based Takeda and its …

May 8, 2015 · Takeda Pharmaceuticals has recently offered to pay over $2 billion to settle over 8,000 Actos bladder cancer lawsuits. The $2.2 billion settlement will resolve Actos lawsuits brought by patients claiming that the type-2 diabetes drug had caused them to …

Apr 9, 2014 · A federal jury in Louisiana has ordered Takeda Pharmaceutical Co. Ltd and Eli Lilly & Co. to pay a staggering $9 billion in damages over allegations that the companies’ diabetes medication, Actos, can cause bladder cancer.

Many of the patients who developed cancer as a result of using Actos® filed lawsuits against Takeda, claiming the company had kept the risks associated with the drug hidden from consumers. Several of the cases went to trial with mixed results.

The Actos® lawsuits included personal injury and wrongful death cases alleging that Takeda failed to properly warn doctors and patients about the serious risks of bladder cancer. A lawsuit was filed by the family of a Louisiana man, who took …